Back

High-dose guideline-directed medical therapy at discharge reduces mortality in hospitalized patients with heart failure with reduced ejection fraction: evidence from the HEROES study

1 September 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Novel therapies in heart failure: impact on outcomes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Pawel Krzesinski

Institute of Military Medicine, Warsaw (Poland)

7 More presentations in this session

Presentation thumbnail
Clinical and echocardiographic long-term follow-up after transcoronary ablation of septal hypertrophy - a retrospective register analysis
Doctor F. Becker (Munich, DE)
Abstract Slides Video
Presentation thumbnail
The association between malnutrition and adverse outcome in patients with chronic heart failure who underwent cardiac resynchronization therapy
Doctor Y. Ono (Oita, JP)
Abstract Slides Video
Presentation thumbnail
Both BNP and left ventricle diastolic diameter can predict all-cause mortality among Colombian asymptomatic, Trypanosoma cruzi-seropositive carriers after 22 years: results of the CHICAMOCHA cohort
Professor J. Villar (Bogota, CO)
Abstract Slides Video
Presentation thumbnail
Prevalence and outcomes of iron deficiency based on transferrin saturation in patients with acute heart failure
Doctor K. Tsuda (Takatsuki, JP)
Abstract Slides Video
Presentation thumbnail
Use of beta-blockers and in-hospital mortality in patients with Takotsubo cardiomyopathy - a systematic review and meta-analysis
Doctor C. Fischer Bacca (Rio do Sul, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Novel therapies in heart failure: impact on outcomes

The Event

Event poster

ESC Congress 2025

1 September 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Patient-dependent factors limiting guideline-directed medical therapy in patients with heart failure with reduced left ventricular ejection fraction undergoing scheduled hospitalization
thumbnail
Congress Presentation
Implementation of recommendations regarding pharmacotherapy optimization in patients with heart failure undergoing scheduled hospitalization - the HEROES study.
thumbnail
Congress Presentation
Assessment of pharmacotherapy modifications during the treatment of episode of acutely decompensated heart failure - the HEROES study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources